Please assess the completion status of the following clinical trial:

Trial Title: Effect of Modified Mirror Therapy in Patients With Upper Limb Hemiparesis After Stroke

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Meeting the diagnostic criteria of stroke, by CT or MRI.~* The first-onset stroke.~* Presenting with unilateral upper limb dysfunction, within Brunnstrom stage Ⅱ to Ⅳ on the affected side, and Ash-worth score ≤2.~* No obvious cognitive impairment, with Mini-Mental State Examination (MMSE) score \>21 points.~* National Institutes of Health Stroke Scale (NIHSS) score \>4 points.~* Stable vital signs, no severe diseases such as cancer, liver or kidney disorders.~* Aged 35-70 years.~* Courses of diseases 2-6 weeks.~Exclusion Criteria:~* Presence of aphasia, apraxia, or hemispatial neglect.~* Presence of hearing, vision, or comprehension impairments that hinder diagnosis and treatment.~* Complicate with traumas, fractures, or other progressive neuro-muscular system diseases.~* Severe spasticity in the upper limbs.~* Severe bone, joint, or muscle deformities or lesions.~* History of mental illness.

- Gender: ALL
- Minimum Age: 35 Years
- Maximum Age: 70 Years
- Healthy Volunteers: f

Study Arms:
- modified mirror therapy+Modified mirror therapy (Type: EXPERIMENTAL): The study lasted 30 days for each participant. The patients enrolled were randomly divided into the experimental group and the control group, all under routine rehabilitation therapy. Additionally, the patients in the experimental group were given modified mirror therapy.
- routine rehabilitation therapy (Type: ACTIVE_COMPARATOR): The study lasted 30 days for each participant. The patients enrolled were randomly divided into the experimental group and the control group, all under routine rehabilitation therapy.

Based on this trial design, predict the completion outcome and termination type (if applicable).